Prostaglandin signalling in cerebral ischaemia

British Journal of Pharmacology

Volumn 160, Issue 4, 2010, Pages 844-846

  Andreasson, Katrin ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral ischaemia; COX 2; EP1 receptor; EP2 receptor; EP3 receptor; EP4 receptor; Excitotoxicity; Vasculature

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; RHO KINASE; SOMATOMEDIN RECEPTOR; NEUROPROTECTIVE AGENT; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN RECEPTOR; PTGER3 PROTEIN, HUMAN;

BRAIN BLOOD FLOW; BRAIN HYPOXIA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CATALYSIS; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; DEGENERATIVE DISEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; EXCITOTOXICITY; HUMAN; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NOTE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; VASOCONSTRICTION; VASODILATATION; ANIMAL; DRUG EFFECTS; ISCHEMIC ATTACK, TRANSIENT; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN ISCHEMIA; CYCLOOXYGENASE 2; HUMANS; ISCHEMIC ATTACK, TRANSIENT; NEURONS; NEUROPROTECTIVE AGENTS; PROSTAGLANDINS; RECEPTORS, PROSTAGLANDIN; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, PROSTAGLANDIN E, EP3 SUBTYPE; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION;

EID: 77952845772     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00715.x     Document Type: Note

References (16)

1. Ahmad AS, Saleem S, Ahmad M, Dore S (2006). Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage. Toxicol Sci 89 : 265 270.
2. 2 receptors in models of neurological disease. Prostaglandins Other Lipid Mediat PMID: 19808012 [Epub ahead of print]. doi:10.1016/j.prostaglandins.2009.04.003
3. 2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis. Ann Neurol 56 : 240 248.
4. Hewett SJ, Bell SC, Hewett JA (2006). Contributions of cyclooxygenase-2 to neuroplasticity and neuropathology of the central nervous system. Pharmacol Ther 112 : 335 357.
5. 3 receptors. Br J Pharmacol 160 : 847 859.
6. Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA et al 2006). Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med 12 : 225 229.
7. 2 receptor agonist, protects against cerebral ischemia. Neurosci Lett 438 : 210 215.
8. Liang X, Wang Q, Hand T, Wu L, Breyer RM, Montine TJ et al 2005). Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease. J Neurosci 25 : 10180 10187.
9. Liang X, Wang Q, Shi J, Lokteva L, Breyer RM, Montine TJ et al 2008). The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis. Ann Neurol 64 : 304 314.
10. 2 EP2 receptor in permanent focal cerebral ischemia. Ann Neurol 57 : 758 761.
11. 2 EP2 receptor in cerebral ischemia. J Neurosci 24 : 257 268.
12. Montine TJ, Milatovic D, Gupta RC, Valyi-Nagy T, Morrow JD, Breyer RM (2002). Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent. J Neurochem 83 : 463 470.
13. Niwa K, Araki E, Morham SG, Ross ME, Iadecola C (2000). Cyclooxygenase-2 contributes to functional hyperemia in whisker-barrel cortex. J Neurosci 20 : 763 770.
14. Saleem S, Li RC, Wei G, Dore S (2007). Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice. J Neurosci Res 85 : 2433 2440.
15. Wu L, Wang Q, Liang X, Andreasson K (2007). Divergent effects of prostaglandin receptor signaling on neuronal survival. Neurosci Lett 421 : 253 258.
16. 2 receptor EP1 inhibition involves the PTEN/AKT pathway. Neurobiol Dis 29 : 543 551.